Work

Recombinant human hyaluronidase (rHuPH20): an enabling platform for subcutaneous drug and fluid administration

Year: 2007

Type: review

Source: Expert Opinion on Drug Delivery

DOI: 10.1517/17425247.4.4.427

Author: Gregory I Frost

Institution: Halozyme Therapeutics (United States)

Language: English

Topic: Proteoglycans and glycosaminoglycans research

Subfield: Cell Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2158548553

FWCI: 0.42

Cites: 66

Cited by: 325

Related to: 10